IA
SWTX

IFP Advisors’s SpringWorks Therapeutics SWTX Stock Holding History

IFP Advisors’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,859
Closed -$331K – 4933
2025
Q2 		$331K Buy
6,859
+2,912
+74% +$130K 0.01% 1018
2025
Q1 		$174K Sell
3,947
-106
-3% -$4.88K 0.01% 1239
2024
Q4 		$146K Buy
4,053
+161
+4% +$5.63K ﹤0.01% 1291
2024
Q3 		$125K Sell
3,892
-174
-4% -$6.5K ﹤0.01% 1311
2024
Q2 		$153K Buy
4,066
+1,278
+46% +$53.8K 0.01% 1171
2024
Q1 		$137K Sell
2,788
-45
-2% -$2.08K 0.01% 1166
2023
Q4 		$103K Sell
2,833
-24
-0.8% -$626 ﹤0.01% 1229
2023
Q3 		$66.1K Buy
2,857
+63
+2% +$1.72K ﹤0.01% 1442
2023
Q2 		$73.3K Buy
2,794
+665
+31% +$17.5K ﹤0.01% 1457
2023
Q1 		$48.2K Sell
2,129
-8
-0.4% -$234 ﹤0.01% 1592
2022
Q4 		$51K Buy
2,137
+16
+0.8% +$394 ﹤0.01% 2243
2022
Q3 		$52K Buy
2,121
+69
+3% +$1.98K ﹤0.01% 2342
2022
Q2 		$51K Hold
2,052
– – ﹤0.01% 2167
2022
Q1 		$51K Buy
2,052
+288
+16% +$16.5K ﹤0.01% 2167
2021
Q4 		$110K Buy
1,764
+783
+80% +$51.8K ﹤0.01% 1231
2021
Q3 		$65K Buy
+981
New +$75.6K ﹤0.01% 1479

Other funds holding SWTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

IFP Advisors's SWTX Position: Q3 2025 in Review

IFP Advisors sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 6,859 shares — an estimated $331K sold.

IFP Advisors first reported a position in SWTX in Q3 2021 and held it in 16 quarters. The position peaked at $331K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

  • IFP Advisors reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
  • IFP Advisors sold 6,859 SpringWorks Therapeutics shares in Q3 2025, an estimated $331K.
  • IFP Advisors first reported a position in SpringWorks Therapeutics in Q3 2021 and held it in 16 quarters.
  • IFP Advisors's SpringWorks Therapeutics position peaked at $331K in Q2 2025.
  • 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on IFP Advisors's 13F filing for Q3 2025, filed 2 Dec 2025.